Terumo Corporation (TRUMY) Financials

TRUMY Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 14.5 billion 4.6 billion
Dec. 31, 2025 14.4 billion 4.7 billion
Sept. 30, 2025 12.8 billion 3.1 billion
June 30, 2025 12.5 billion 3.0 billion

TRUMY Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 340.8 million ?
Dec. 31, 2025 164.0 million ?
Sept. 30, 2025 355.1 million ?
June 30, 2025 108.8 million ?

TRUMY Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 168.1 million
Dec. 31, 2025 212.2 million
Sept. 30, 2025 241.0 million
June 30, 2025 291.0 million

TRUMY Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.8 billion 628.2 million -
Dec. 31, 2025 1.5 billion 638.1 million -
Sept. 30, 2025 1.5 billion 674.9 million -
June 30, 2025 1.4 billion 694.5 million 271.8 million

TRUMY Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 9.4 million
Sept. 30, 2025 10.0 million
June 30, 2025 10.3 million

TRUMY Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 224.6 million - 732.0 million -
Dec. 31, 2025 94.6 million - 684.0 million -
Sept. 30, 2025 128.5 million - 672.9 million -
June 30, 2025 118.2 million - 639.6 million -

TRUMY Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 1.9 billion 964.6 million
Dec. 31, 2025 1.9 billion 932.1 million
Sept. 30, 2025 1.9 billion 879.7 million
June 30, 2025 1.8 billion 796.2 million

TRUMY

Price: $14.03

52 week price:
12.08
20.12

Dividend Yield: 1.25%

Payout Ratio Range:
-192.31%
185.25%

Earnings Per Share: 0.58 USD

P/E Ratio: 25.59

Exchange: PNK

Sector: Healthcare

Industry: Medical Instruments & Supplies

Market Capitalization: 21.9 billion

Links: